KRISTIN HELLQUIST

- CMS: Signed on to ASM letter Re: Unleashing Prosperity Through Deregulation of the Medicare Program Request for Information - DOJ: Signed on to ASM letter Re: Anticompetitive Regulations Task Force Public Inquiry (Docket No. ATR-2025-0001) - Signed on to ASM letter to bill sponsors RE: Support of H.R. 3890, the Resident Physician Shortage Reduction Act

- US Senate: Signed on ASM Letter RE: Support of S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly (No UPCODE) Act - US Congress: Signed on ASM Letter RE: Support of the Resident Physician Shortage Reduction Act (S.2439/H.R.4731) - CMS: Signed onto ASM Letter RE: Medicare and Medicaid Programs; CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

- Opposed S. 106/H.R. 539, the Chiropractic Medicare Coverage Modernization Act of 2025 - Letter to Congressional leadership calling for appropriations bill to reverse Medicare payment cuts and provide physicians with payment increase - CMS: Signed on ASM Letter Re: CY 2026 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P) - Signed on to ASM letter to bill sponsors RE: Comments on draft legislation to improve the Medicare GME program

- US House of Representatives: Signed on ASM Letter RE: Support for H.R. 5509, the Safe Step Act - US Senate: Signed on ASM Letter RE: Support for S. 2903, the Safe Step Act

- US Congress: Signed on ASM Letter RE: Urge Congressional action to stop a portion of the recently finalized rule published by the Centers for Medicare & Medicaid Services (CMS) on October 31st (90 Fed. Reg. 32352 et seq.), that reduces the work Relative Value Units (RVUs) and intra-service time for all non-time-based codes by 2.5 percent in 2026, with additional reductions expected every 3 years indefinitely. - US House of Representatives: Signed on ASM Letter RE: Commend House Appropriations Committee for unanimously adopting an amendment that would halt funding for implementation of the Medicare Wasteful and Inappropriate Service Reduction (WISeR) Model in the Fiscal Year 2026 appropriations legislation - US House of Representatives: Signed on ASM Letter Re: Support of H.R. 6160, the Strengthening Medicare for Patients and Providers Act

- Opposed S. 106/H.R. 539, the Chiropractic Medicare Coverage Modernization Act of 2025 - Letter to Congressional leadership calling for appropriations bill to reverse Medicare payment cuts and provide physicians with payment increase - CMS: Signed on ASM Letter Re: CY 2026 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P) - Signed on to ASM letter to bill sponsors RE: Comments on draft legislation to improve the Medicare GME program

- US Senate: Signed on ASM Letter RE: Support of S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly (No UPCODE) Act - US Congress: Signed on ASM Letter RE: Support of the Resident Physician Shortage Reduction Act (S.2439/H.R.4731) - CMS: Signed onto ASM Letter RE: Medicare and Medicaid Programs; CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

- US House of Representatives: SUNucate Coalition Letter to House Subcommittee on Health: RE: Support H.R. 3686, the SAFE Sunscreen Standards Act - US Congress: SUNucate Coalition Letter RE: Support S.2292, the Over-the-Counter Monograph Drug User Fee Amendments

- US Senate: Signed on ASM Letter RE: Support of S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly (No UPCODE) Act - US Congress: Signed on ASM Letter RE: Support of the Resident Physician Shortage Reduction Act (S.2439/H.R.4731) - CMS: Signed onto ASM Letter RE: Medicare and Medicaid Programs; CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

- US House of Representatives: Signed on ASM Letter RE: Support for H.R. 5509, the Safe Step Act - US Senate: Signed on ASM Letter RE: Support for S. 2903, the Safe Step Act

- Letter to House Energy and Commerce Committee on RE: Physician Payment Reform Outline - Letter to House Members on Support of H.R. 10073, the Medicare Patient Access and Practice Stabilization Act of 2024 - Supported HR 10073: Medicare Patient Access and Practice Stabilization Act of 2024

- Opposed H.R. 1770/S. 2477 - Letter to FDA on Preventing Counterfeit Drugs & Devices (Botox) - Letter to Surgeon General to to renew the Call to Action to Prevent Skin Cancer

- Letter to CMS on Medicare Program; Request for Information on Medicare Advantage Data - Letter to Senate Finance Committee on Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B - Letter to Senate Finance Committee on Bipartisan Medicare GME Working Group Draft Proposal Outline - Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act

-Called on Congress to quickly pass legislation that would reverse the 3.37% Medicare Physician Payment cut that went into effect Jan 1st -Supported H.R. 6683, "Preserving Seniors' Access to Physicians Act" -CMS: Signed on ASM Letter RE: Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies -Letter to CMS urging them to propose a Star Ratings Measure based on a survey of physicians' experiences with Medicare Advantage plans, and asking them to adopt this measure for CY 2026 and beyond

-Called on Congress to quickly pass legislation that would reverse the 3.37% Medicare Physician Payment cut that went into effect Jan 1st -Supported H.R. 6683, "Preserving Seniors' Access to Physicians Act" -CMS: Signed on ASM Letter RE: Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies -Letter to CMS urging them to propose a Star Ratings Measure based on a survey of physicians' experiences with Medicare Advantage plans, and asking them to adopt this measure for CY 2026 and beyond

- Letter to Congressional Leaders on opposing The Biosimilar Red Tape Elimination Act (S.2305)

- Opposed H.R. 1770/S. 2477 - Letter to FDA on Preventing Counterfeit Drugs & Devices (Botox) - Letter to Surgeon General to to renew the Call to Action to Prevent Skin Cancer

- Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act - Supported S. 652/H.R. 2389, the Resident Physician Shortage Reduction Act - Supported S. 652/H.R. 2630, the Safe STEP Act - Letter to CMS on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges - Letter to CMS on Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications - Health Care Workforce Shortages RFI - encourages the committee to authorize a loan repayment program for specialty physicians modeled after section 781 of the Public Health Service Act (PHSA), signed into law in 2018 as section 7071 of the SUPPORT for Patients and Communities Act (P.L. 115-271). - Letter to Senate HELP Committee on Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization RFI - Letter to Office of Human Services Policy - Improving Care Delivery and Integrating Specialty Care in Population-Based Models Request for Input (RFI)

- Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act

- Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act - Opposed Implementing G2211 - Letter sent to House urging Congress to halt the implementation of Healthcare Common Procedure Coding Systems add-on code G2211 - Called on Congress to prevent a 3.37% cut to Medicare reimbursement Payments for 2024 - Supported Specialty Physicians Advancing Rural Care (SPARC) Act. (S. 705/ H.R. 2761) - Urged the Medicare Payment Advisory Commission to recommend a positive Medicare base payment rate update for physician and other health professional services equal to the projected increase in the Medicare Economic Index (MEI) for calendar year (CY) 2025

- Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act - Letter to CMS on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges - Letter to CMS on Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications - Health Care Workforce Shortages RFI - encourages the committee to authorize a loan repayment program for specialty physicians modeled after section 781 of the Public Health Service Act (PHSA), signed into law in 2018 as section 7071 of the SUPPORT for Patients and Communities Act (P.L. 115-271). - Letter to Senate HELP Committee on Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization RFI - Letter to Office of Human Services Policy - Improving Care Delivery and Integrating Specialty Care in Population-Based Models Request for Input (RFI)

- Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act - Supported S. 652/H.R. 2389, the Resident Physician Shortage Reduction Act - Supported S. 652/H.R. 2630, the Safe STEP Act - Letter to CMS on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges - Letter to CMS on Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications - Health Care Workforce Shortages RFI - encourages the committee to authorize a loan repayment program for specialty physicians modeled after section 781 of the Public Health Service Act (PHSA), signed into law in 2018 as section 7071 of the SUPPORT for Patients and Communities Act (P.L. 115-271). - Letter to Senate HELP Committee on Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization RFI - Letter to Office of Human Services Policy - Improving Care Delivery and Integrating Specialty Care in Population-Based Models Request for Input (RFI)

- Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act - Supported S. 652/H.R. 2389, the Resident Physician Shortage Reduction Act - Supported S. 652/H.R. 2630, the Safe STEP Act - Letter to CMS on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges - Letter to CMS on Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications - Health Care Workforce Shortages RFI - encourages the committee to authorize a loan repayment program for specialty physicians modeled after section 781 of the Public Health Service Act (PHSA), signed into law in 2018 as section 7071 of the SUPPORT for Patients and Communities Act (P.L. 115-271). - Letter to Senate HELP Committee on Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization RFI - Letter to Office of Human Services Policy - Improving Care Delivery and Integrating Specialty Care in Population-Based Models Request for Input (RFI)

- Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act - Opposed Implementing G2211 - Letter sent to House urging Congress to halt the implementation of Healthcare Common Procedure Coding Systems add-on code G2211 - Called on Congress to prevent a 3.37% cut to Medicare reimbursement Payments for 2024 - Supported Specialty Physicians Advancing Rural Care (SPARC) Act. (S. 705/ H.R. 2761) - Urged the Medicare Payment Advisory Commission to recommend a positive Medicare base payment rate update for physician and other health professional services equal to the projected increase in the Medicare Economic Index (MEI) for calendar year (CY) 2025

- Called on FDA for Enhanced Patient Safety of Medical Devices for Patients with All Skin Types - Supported Finalization of Sunlamp Rule and Amendment to Performance Standard (General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products (Docket No. FDA-2015-N- 1765); and the Sunlamp Products; Proposed Amendment to Performance Standard (Docket No. FDA- 1998-N-0880)) - Supported H Res 365 - Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection.

- Called on FDA for Enhanced Patient Safety of Medical Devices for Patients with All Skin Types - Supported Finalization of Sunlamp Rule and Amendment to Performance Standard (General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products (Docket No. FDA-2015-N- 1765); and the Sunlamp Products; Proposed Amendment to Performance Standard (Docket No. FDA- 1998-N-0880)) - Supported H Res 365 - Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection.

- Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act - Supported S. 652/H.R. 2389, the Resident Physician Shortage Reduction Act - Supported S. 652/H.R. 2630, the Safe STEP Act - Letter to CMS on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges - Letter to CMS on Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications - Health Care Workforce Shortages RFI - encourages the committee to authorize a loan repayment program for specialty physicians modeled after section 781 of the Public Health Service Act (PHSA), signed into law in 2018 as section 7071 of the SUPPORT for Patients and Communities Act (P.L. 115-271). - Letter to Senate HELP Committee on Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization RFI - Letter to Office of Human Services Policy - Improving Care Delivery and Integrating Specialty Care in Population-Based Models Request for Input (RFI)

- Supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act - Opposed Implementing G2211 - Letter sent to House urging Congress to halt the implementation of Healthcare Common Procedure Coding Systems add-on code G2211 - Called on Congress to prevent a 3.37% cut to Medicare reimbursement Payments for 2024 - Supported Specialty Physicians Advancing Rural Care (SPARC) Act. (S. 705/ H.R. 2761) - Urged the Medicare Payment Advisory Commission to recommend a positive Medicare base payment rate update for physician and other health professional services equal to the projected increase in the Medicare Economic Index (MEI) for calendar year (CY) 2025

Recommendations to Improve Utilization Management and Advance Specialty-Focused Alternative Payment Models, Safe Step Act (H.R. 2163/S. 464) Supported the Consensus Statement on Improving the Prior Authorization Process, as well as the American Medical Association (AMA) Prior Authorization and Utilization Management Reform Principles.

-Request for Information (RFI): HHS Initiative To Strengthen Primary Health Care - shared feedback in response to the aforementioned request for information (RFI) from the perspective of practicing specialty medicine providers, urging Health and Human services to work with the Centers for Medicare & Medicaid Services to ensure that the Quality Payment Program (QPP) offers more clinically relevant participation pathways for specialists that result in truly meaningful improvements to patient care. -Expressed support for Getting Over Lengthy Delays in Care As Required by Doctors (GOLD CARD) Act of 2022 (H.R. 7995) legislation. Supports Congress working to advance legislation which would reduce the administrative burdens of prior authorization in the Medicare Advantage program to ensure safe, timely, and affordable access to care for patients. -Supports H.R. 3173, the Improving Seniors Timely Access to Care Act, which would improve the prior authorization process in Medicare Advantage plans through increased transparency and the establishment of an electronic prior authorization process and urges Congress to advance this legislation -Supported legislative action to mitigate scheduled cuts generated by changes within the Medicare Physician Fee Schedule (MPFS). These critical payment reduction relief policies provided increased financial stability for Medicare clinicians and helped to ensure our nations seniors maintained access to high-quality care. -We continue to be deeply alarmed about the mounting financial instability of the Medicare physician payment system. Strongly urged Congress to address the looming Medicare cuts in 2023 by establishing a permanent Medicare payment system that improves and preserves patient access to physician care. -Applauds the introduction of H.R. 8800, the Supporting Medicare Providers Act of 2022. This critical legislation provides a 4.42% positive adjustment to the Medicare Physician Fee Schedule (MPFS) conversion factor (CF) for CY2023, thereby mitigating payment cuts within the MPFS that are anticipated to take effect on January 1, 2023.

-Request for Information (RFI): HHS Initiative To Strengthen Primary Health Care - shared feedback in response to the aforementioned request for information (RFI) from the perspective of practicing specialty medicine providers, urging Health and Human services to work with the Centers for Medicare & Medicaid Services to ensure that the Quality Payment Program (QPP) offers more clinically relevant participation pathways for specialists that result in truly meaningful improvements to patient care. -Expressed support for Getting Over Lengthy Delays in Care As Required by Doctors (GOLD CARD) Act of 2022 (H.R. 7995) legislation. Supports Congress working to advance legislation which would reduce the administrative burdens of prior authorization in the Medicare Advantage program to ensure safe, timely, and affordable access to care for patients. -Supports H.R. 3173, the Improving Seniors Timely Access to Care Act, which would improve the prior authorization process in Medicare Advantage plans through increased transparency and the establishment of an electronic prior authorization process and urges Congress to advance this legislation -Supported legislative action to mitigate scheduled cuts generated by changes within the Medicare Physician Fee Schedule (MPFS). These critical payment reduction relief policies provided increased financial stability for Medicare clinicians and helped to ensure our nations seniors maintained access to high-quality care. -We continue to be deeply alarmed about the mounting financial instability of the Medicare physician payment system. Strongly urged Congress to address the looming Medicare cuts in 2023 by establishing a permanent Medicare payment system that improves and preserves patient access to physician care. -Applauds the introduction of H.R. 8800, the Supporting Medicare Providers Act of 2022. This critical legislation provides a 4.42% positive adjustment to the Medicare Physician Fee Schedule (MPFS) conversion factor (CF) for CY2023, thereby mitigating payment cuts within the MPFS that are anticipated to take effect on January 1, 2023.

- Strong opposition to H.R. 8812, the Improving Care and Access to Nurses Act, or the I CAN Act. In general, we are deeply concerned that this broad, sweeping bill endangers the care of Medicare and Medicaid patients by expanding the types of services NPPs can perform and removing physician involvement in patient care under expanded scope of practice. - Request for Information on the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.Suggest actions Congress should take to stabilize the Medicare payment system while ensuring successful value-based care incentives are available for specialty physicians. ASDSA has serious concerns about structural and mounting instability in Medicare payments to physicians and request assistance in urging the committees of jurisdiction to hold hearings to begin the process of stabilizing and improving Medicare physician reimbursement and performance programs. - Applauds the introduction of H.R. 8800, the Supporting Medicare Providers Act of 2022. ASDSA strongly supports H.R. 8800 as an essential step toward providing clinicians with financial stability and ensuring patients have access to critical services our members provide. Steps must be taken to identify and advance systemic Medicare payment reforms designed to ensure longer‐term stability for clinicians, promote and reward value‐based care, advance health equity and reduce disparities within the Medicare system. - Letter to FDA, Center for Drug Evaluation and Research (CDER). We strongly ask that CDER office nominate a candidate who is board certified in dermatology when the time comes to fill the position of director of the Division of Dermatology and Dentistry at the FDA. We take note that few dermatologists currently serve in the Division and have specific concerns about how this may affect future decisions made regarding dermatologic surgery and patient safety. - Letter supporting the FDA as they work to finalize its proposed rules entitled General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products (Docket No. FDA-2015-N-1765); and the Sunlamp Products; Proposed Amendment to Performance Standard (Docket No. FDA-1998-N-0880) We are deeply concerned that the publics health continues to be at risk due to insufficient sunlamp regulation and believe the public would greatly benefit from FDAs finalizing these proposed rules. We strongly encourage the FDA to expeditiously finalize rules to restrict minors use of sunlamps, to require risk acknowledgement certification from adults, and to strengthen the sunlamp performance standards. - Alongside National Council on Skin Cancer Prevention (NCSCP), ASDSA requests that the Food and Drug Administration, working with the Department of Health and Human Services, finalize the proposed rules entitled General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products (Docket No. FDA-2015-N-1765); and the Sunlamp Products; Proposed Amendment to Performance Standard (Docket No. FDA-1998-N-0880) published by the FDA in the Federal Register on December 22, 2015. We request to meet with FDA and look forward to continuing our collaboration in furtherance of protecting the publics health.

-Request for Information (RFI): HHS Initiative To Strengthen Primary Health Care - shared feedback in response to the aforementioned request for information (RFI) from the perspective of practicing specialty medicine providers, urging Health and Human services to work with the Centers for Medicare & Medicaid Services to ensure that the Quality Payment Program (QPP) offers more clinically relevant participation pathways for specialists that result in truly meaningful improvements to patient care. -Expressed support for Getting Over Lengthy Delays in Care As Required by Doctors (GOLD CARD) Act of 2022 (H.R. 7995) legislation. Supports Congress working to advance legislation which would reduce the administrative burdens of prior authorization in the Medicare Advantage program to ensure safe, timely, and affordable access to care for patients. -Supports H.R. 3173, the Improving Seniors Timely Access to Care Act, which would improve the prior authorization process in Medicare Advantage plans through increased transparency and the establishment of an electronic prior authorization process and urges Congress to advance this legislation -Supported legislative action to mitigate scheduled cuts generated by changes within the Medicare Physician Fee Schedule (MPFS). These critical payment reduction relief policies provided increased financial stability for Medicare clinicians and helped to ensure our nations seniors maintained access to high-quality care. -We continue to be deeply alarmed about the mounting financial instability of the Medicare physician payment system. Strongly urged Congress to address the looming Medicare cuts in 2023 by establishing a permanent Medicare payment system that improves and preserves patient access to physician care. -Applauds the introduction of H.R. 8800, the Supporting Medicare Providers Act of 2022. This critical legislation provides a 4.42% positive adjustment to the Medicare Physician Fee Schedule (MPFS) conversion factor (CF) for CY2023, thereby mitigating payment cuts within the MPFS that are anticipated to take effect on January 1, 2023.

- Strong opposition to H.R. 8812, the Improving Care and Access to Nurses Act, or the I CAN Act. In general, we are deeply concerned that this broad, sweeping bill endangers the care of Medicare and Medicaid patients by expanding the types of services NPPs can perform and removing physician involvement in patient care under expanded scope of practice. - Request for Information on the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.Suggest actions Congress should take to stabilize the Medicare payment system while ensuring successful value-based care incentives are available for specialty physicians. ASDSA has serious concerns about structural and mounting instability in Medicare payments to physicians and request assistance in urging the committees of jurisdiction to hold hearings to begin the process of stabilizing and improving Medicare physician reimbursement and performance programs. - Applauds the introduction of H.R. 8800, the Supporting Medicare Providers Act of 2022. ASDSA strongly supports H.R. 8800 as an essential step toward providing clinicians with financial stability and ensuring patients have access to critical services our members provide. Steps must be taken to identify and advance systemic Medicare payment reforms designed to ensure longer‐term stability for clinicians, promote and reward value‐based care, advance health equity and reduce disparities within the Medicare system. - Letter to FDA, Center for Drug Evaluation and Research (CDER). We strongly ask that CDER office nominate a candidate who is board certified in dermatology when the time comes to fill the position of director of the Division of Dermatology and Dentistry at the FDA. We take note that few dermatologists currently serve in the Division and have specific concerns about how this may affect future decisions made regarding dermatologic surgery and patient safety. - Letter supporting the FDA as they work to finalize its proposed rules entitled General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products (Docket No. FDA-2015-N-1765); and the Sunlamp Products; Proposed Amendment to Performance Standard (Docket No. FDA-1998-N-0880) We are deeply concerned that the publics health continues to be at risk due to insufficient sunlamp regulation and believe the public would greatly benefit from FDAs finalizing these proposed rules. We strongly encourage the FDA to expeditiously finalize rules to restrict minors use of sunlamps, to require risk acknowledgement certification from adults, and to strengthen the sunlamp performance standards. - Alongside National Council on Skin Cancer Prevention (NCSCP), ASDSA requests that the Food and Drug Administration, working with the Department of Health and Human Services, finalize the proposed rules entitled General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products (Docket No. FDA-2015-N-1765); and the Sunlamp Products; Proposed Amendment to Performance Standard (Docket No. FDA-1998-N-0880) published by the FDA in the Federal Register on December 22, 2015. We request to meet with FDA and look forward to continuing our collaboration in furtherance of protecting the publics health.

Recommendations to Improve Utilization Management and Advance Specialty-Focused Alternative Payment Models, Safe Step Act (H.R. 2163/S. 464) Supported the Consensus Statement on Improving the Prior Authorization Process, as well as the American Medical Association (AMA) Prior Authorization and Utilization Management Reform Principles.

HR 1868/Medicare sequester MACRA oversight

HR 5- Equality Act Graduate Medical Education

EFT fees being charged to physicians HR 5239/S 2941 - Good Samaritan Health Professionals Act Interim Final Rule Requirements Related to Surprise Billing: Part II

Indoor tanning ban (HRes 436) Coronavirus Provider Protection Act Change the name of the "General and Plastic Surgery Devices Panel" Request for melanoma funding in Defense appropriations

EFT fees being charged to physicians HR 5239/S 2941 - Good Samaritan Health Professionals Act Interim Final Rule Requirements Related to Surprise Billing: Part II

Medicare Physician Fee Schedule/stabilizing provider payments; MACRA S. 3019 - Improving Seniors' Timely Access to Care Act

HR 1379 IT Strategic Health Plan

Medicare Advantage plans on prior authorization Safe Harbor Protections (RIN- 0936-AA08; 01G-0936-P) Surprise Billing - General topic - no specific bill Veterans Community Care Program RIN- 2900-AQ46) S. 348, H.R. 1763 Resident Physician Shortage Reduction Act

Reducing Physician Administrative Burden Opposing H.R. 2143 Comments on CMS Patient Access and Interoperability Comments on ONC Interoperability Comments on MACRA

H.R 2279/S 2546: Safe Step Scope of Practice and Reimbursement for PAs

CMS: Patients Over Paperwork - Reducing Burden HR 3107: Senior Access to Timely Care 2020 MPFS QPP Proposed Rule 2019 MDT Repeal

HRes323, Skin Cancer Caucus, Access to sunscreen

H.R 2279/S 2546: Safe Step Scope of Practice and Reimbursement for PAs

Medicare Advantage plans on prior authorization Safe Harbor Protections (RIN- 0936-AA08; 01G-0936-P) Surprise Billing - General topic - no specific bill Veterans Community Care Program RIN- 2900-AQ46) S. 348, H.R. 1763 Resident Physician Shortage Reduction Act

Medicare CY 2019 Physician Fee Schedule CMS Risk Adjustment Program CMS Stark Law RFI MIPS Medicare Local Coverage Determination (HR 3635) Resident Physician Shortage Reduction Act (HR 2267/S 1301)

Medicare CY 2019 Physician Fee Schedule CMS Risk Adjustment Program CMS Stark Law RFI MIPS Medicare Local Coverage Determination (HR 3635) Resident Physician Shortage Reduction Act (HR 2267/S 1301)

USPSTF Transparency and Accountability Act (HR 539)

Insanitary Conditions at Compounding Facilities Support for HRES 282: OTC sunscreen use at school

Medicare CY 2019 Physician Fee Schedule CMS Risk Adjustment Program CMS Stark Law RFI MIPS Medicare Local Coverage Determination (HR 3635) Resident Physician Shortage Reduction Act (HR 2267/S 1301)

Medical liability reform (HR 1215/the "Protecting Access to Care Act"; HR 1565/"Saving Lives, Saving Costs Act"; HR 1704/"ACCESS ACT") Protections for health care professionals acting in times of national emergency (HR 1876/the "Good Samaritan Health Professionals Act")

Medical liability reform (HR 1215/the "Protecting Access to Care Act"; HR 1565/"Saving Lives, Saving Costs Act"; HR 1704/"ACCESS ACT") Protections for health care professionals acting in times of national emergency (HR 1876/the "Good Samaritan Health Professionals Act")

Determining the intended use of drugs and/or devices and using scientific exchange to share data on "Off-label use" (HR 1703/Medical Products Communications Act of 2017)

Medical liability reform (HR 1215/the "Protecting Access to Care Act"; HR 1565/"Saving Lives, Saving Costs Act"; HR 1704/"ACCESS ACT") Protections for health care professionals acting in times of national emergency (HR 1876/the "Good Samaritan Health Professionals Act")

Recommendations on health care reform legislation in the House and Senate Prohibiting HHS or any state from requiring a health care provider, as a condition of licensure, to comply with the requirements of meaningful use of electronic health records (HR 1766/Medical Practice Freedom Act)

Medical liability reform (HR 1215/the "Protecting Access to Care Act"; HR 1565/"Saving Lives, Saving Costs Act"; HR 1704/"ACCESS ACT") Protections for health care professionals acting in times of national emergency (HR 1876/the "Good Samaritan Health Professionals Act")

Reauthorization of CHIP (HR 3922) Marketplace network adequacy in the ACA

Truth in Healthcare Marketing Act of 2017 (HR 3928)

Repeal of IPAB (HR 849) Recommendations changes to MACRA Recommendations to CMMI Medicare beneficiary payment options (HR 4133)

Transparency and accountability of the United States Preventive Services Task Force (HR 539/the USPSTF Transparency and Accountability Act of 2017) Certified electronic health record technology - deferment from implementing 2015 Edition CEHRT

Repeal of the Independent Payment Advisory Board (HR 849/Protecting Seniors' Access to Medicare Act; S. 260/Protecting Seniors' Access to Medicare Act; S. 251/Protecting Medicare from Executive Action Act)

Repeal of IPAB (HR 849) Recommendations changes to MACRA Recommendations to CMMI Medicare beneficiary payment options (HR 4133)

Repeal of the Independent Payment Advisory Board (HR 849/Protecting Seniors' Access to Medicare Act; S. 260/Protecting Seniors' Access to Medicare Act; S. 251/Protecting Medicare from Executive Action Act)

Repeal of the Independent Payment Advisory Board (HR 849/Protecting Seniors' Access to Medicare Act; S. 260/Protecting Seniors' Access to Medicare Act; S. 251/Protecting Medicare from Executive Action Act)

US Preventive Services Task Force/HR 1151

US Preventive Services Task Force/HR 1151 Meaningful Use relief (S 3173/EHR Regulatory Relief Act)

US Preventive Services Task Force/HR 1151

Support of HR 34, the "21st Century Cures Act"

Medicare Part B Drug Payment Models; Medicare Administrative Contractor Contracts; Medicare Advantage Plans (SB 2392/HR 4227)

Medical liability reform (HR 4771/HEALTH Act of 2016)

Graduate Medical Education (HR 4774/Training Tomorrow's Doctors Today Act)

Notice of Proposed Rulemaking on Merit-based Incentive Payment Plans and Alternative Payment Models under MACRA; in-office ancillary services exception in Medicare/HR 5088; Program Enhancements to the Provider Enrollment Process

H.R. 5926, the FY 2017 Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act - usage of the phrase "non-burning sunshine"

Sunshine Act payments/S. 2978

US Preventive Services Task Force/HR 1151 Meaningful Use relief (S 3173/EHR Regulatory Relief Act)

MACRA, Medicare Physician Fee Schedule, Recovery Audit Contractors process (H.R. 2568/Fair Medical Audits Act of 2015)

Electronic Health Records (H.R. 3940/The Meaningful Use Hardship Relief Act)